Profil
Yasushi Sakai served as an Outside Director at SB-Kawasumi Laboratories, Inc. and later worked at Olympus Corp.
as the Chief Financial Officer from 2019 to 2020.
Anciens postes connus de Yasushi Sakai
| Sociétés | Poste | Fin |
|---|---|---|
| KAWASUMI LABORATORIES, INCORPORATED | Director/Board Member | 30/09/2021 |
| OLYMPUS CORPORATION | Director of Finance/CFO | 01/04/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OLYMPUS CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
SB-Kawasumi Laboratories, Inc.
 SB-Kawasumi Laboratories, Inc. Medical SpecialtiesHealth Technology Kawasumi Laboratories, Inc. engages in the manufacture and sale of medical devices and pharmaceuticals. It operates through the Hemodialysis and Plasmapheresis; and Blood Transfusion and Endovascular segments. The Hemodialysis and Plasmapheresis segment develops, produces, and sells dialyzers, blood tubing lines, arteriovenous fistula needles, and isotonic sodium chloride solutions. It also offers removal of pathogenic factors from blood by extracorporeal circulation. The Blood Transfusion and Endovascular segment offers infusion therapy products, blood bags, apheresis kits, and intravenous sets. The company was founded by Takumi Kawano on December 1, 1954 and is headquartered in Tokyo, Japan. | Health Technology |
